126 related articles for article (PubMed ID: 7530777)
1. Patterns of reactivity with anti-glycolipid antibodies in human primary brain tumors.
Li J; Pearl DK; Pfeiffer SE; Yates AJ
J Neurosci Res; 1994 Oct; 39(2):148-58. PubMed ID: 7530777
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotypic characterization of infiltrating polynuclear and mononuclear cells in childhood brain tumors.
Bodey B; Bodey B; Siegel SE
Mod Pathol; 1995 Apr; 8(3):333-8. PubMed ID: 7617661
[TBL] [Abstract][Full Text] [Related]
3. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
[TBL] [Abstract][Full Text] [Related]
4. Annexin II marks astrocytic brain tumors of high histologic grade.
Roseman BJ; Bollen A; Hsu J; Lamborn K; Israel MA
Oncol Res; 1994; 6(12):561-7. PubMed ID: 7787249
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
[TBL] [Abstract][Full Text] [Related]
6. [Mouse fetal brain specific protein "GP68" is expressed in human tumor cells].
Akimoto J; Ikeda K; Tomonaga M; Saito F; Miwa T; Awaya A; Hashimoto Y; Fukui H
No To Shinkei; 1991 Jan; 43(1):25-9. PubMed ID: 1647189
[TBL] [Abstract][Full Text] [Related]
7. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
8. Role of gemistocytes in astrocytoma progression.
Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
[TBL] [Abstract][Full Text] [Related]
9. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
10. Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins.
Friedlander DR; Zagzag D; Shiff B; Cohen H; Allen JC; Kelly PJ; Grumet M
Cancer Res; 1996 Apr; 56(8):1939-47. PubMed ID: 8620517
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to stage-specific fetal brain 68-kDa glycoprotein (FGP68) revealed increased FGP68 expression in human primary brain tumors.
Kato S; Shinozawa T; Nagashige H; Nakamura M; Asano Y; Takikawa M; Kato M; Awaya A; Hirano A; Ohama E
Acta Neuropathol; 2002 Jul; 104(1):57-66. PubMed ID: 12070665
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of Hsp-27 in astrocytic brain tumors: an immunohistochemical study.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Varakis I
Anticancer Res; 1997; 17(4A):2677-82. PubMed ID: 9252700
[TBL] [Abstract][Full Text] [Related]
14. The expression of the epitope H recognized by the monoclonal antibody H is higher in astrocytomas compared to anaplastic astrocytomas and glioblastomas.
Arvanitis DL; Arvanitis LD; Panourias IG; Kitsoulis P; Kanavaros P
Histol Histopathol; 2005 Oct; 20(4):1057-63. PubMed ID: 16136487
[TBL] [Abstract][Full Text] [Related]
15. Antigenic heterogeneity of human brain tumors defined by monoclonal antibodies.
Stavrou D; Bise K; Groeneveld J; Stocker U; Kretzschmar HA; Keiditsch E; Mehraein P
Anticancer Res; 1989; 9(6):1489-96. PubMed ID: 2697177
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and alterations in telomere length in human brain tumors.
Hiraga S; Ohnishi T; Izumoto S; Miyahara E; Kanemura Y; Matsumura H; Arita N
Cancer Res; 1998 May; 58(10):2117-25. PubMed ID: 9605755
[TBL] [Abstract][Full Text] [Related]
17. CD44 expression in astrocytic tumors.
Ylagan LR; Quinn B
Mod Pathol; 1997 Dec; 10(12):1239-46. PubMed ID: 9436970
[TBL] [Abstract][Full Text] [Related]
18. Production and characterization of monoclonal antibodies to the myelin glycolipid sulfatide.
Hofstetter W; Bologa L; Wetterwald A; Z'graggen A; Blaser K; Herschkowitz N
J Neurosci Res; 1984; 11(4):341-50. PubMed ID: 6379201
[TBL] [Abstract][Full Text] [Related]
19. A2B5 lineages of human astrocytic tumors and their recurrence.
Xia CL; Du ZW; Liu ZY; Huang Q; Chan WY
Int J Oncol; 2003 Aug; 23(2):353-61. PubMed ID: 12851684
[TBL] [Abstract][Full Text] [Related]
20. Correlation of endothelial nitric oxide synthase and vascular endothelial growth factor expression with malignancy in patients with astrocytic tumors.
Erdamar S; Bagci P; Oz B; Dirican A
J BUON; 2006; 11(2):213-6. PubMed ID: 17318973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
